Product description

A NOVEL & PIONEER INTERVENTION FOR MULTIPLE SCLEROSIS WITH CLINICAL STUDY PHASE III
NEUROASPIS  is probably the first patented combination and specially formulated dietary supplement in Europe used for medical purposes in order to support the treatment of MS patients in particular and other related neurodegenerative diseases.

Through a diligent examination of the disease’s modus operandi through a systems medicine approach, the ingredients and their relative concentrations were chosen so the cocktail provides the evident neuro-protective benefits. 

NEUROASPIS  is a product of more than 10 years of research and clinical development, where the Clinical Studies Phase II and Phase III are published in 2013 and 2022 accordingly in BMJ.

Read more

Specifications

Categories Branded Finished Products
Supplied from Greece
Product Applications Dietary Supplements
Product Certifications Health & Safety (GMP, HAACP and equivalents)

More products from Aniva International SA

View all our products (10)

Products from other suppliers